Ameritas Investment Partners, Inc. - INNOVATE BIOPHARMACEUTICLS I ownership

Back to all holdings Add to watchlist

INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 48 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q3 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of INNOVATE BIOPHARMACEUTICLS I
ValueSharesWeighting
Q1 2019$3,0000.0%1,4500.0%0.00%–
Q4 2018$3,000
-70.0%
1,4500.0%0.00%–
Q3 2018$10,000
-70.6%
1,4500.0%0.00%
-100.0%
Q2 2018$34,000–1,450–0.00%–
 Download
Other shareholders

There were no reported owners of INNOVATE BIOPHARMACEUTICLS I in Q3 2018.

NameSharesValueWeighting ↓
View complete list of INNOVATE BIOPHARMACEUTICLS I shareholders